Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project.
暂无分享,去创建一个
J S Martin | T. Aufderheide | W. Weaver | J. Martin | David O. Williams | T. Feldman | M. Sherrid | D. Kereiakes | J. Anderson | G. McKendall | W D Weaver | Jenny S. Martin | D O Williams | T. Feldman | B. Gibler | D. Williams | L. Martin | L. Anderson | J L Anderson | D J Kereiakes | S. Teichman | T Feldman | B Gibler | T Aufderheide | L H Martin | L C Anderson | Linda H. Martin | Jeffrey L. Anderson | Henry M. Greenberg
[1] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[2] E. Veys,et al. Letter: HL-A and infective sacroileitis. , 1974, Lancet.
[3] R Roberts,et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.
[4] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[5] W. Weaver,et al. Potential use of thrombolytic therapy before hospitalization. , 1989, The American journal of cardiology.
[6] A. Jaffe,et al. Recent changes in management of acute myocardial infarction: implications for emergency care physicians. , 1988, Journal of the American College of Cardiology.
[7] Dwight E. Peake,et al. Thrombolysis in myocardial infarction (TIMI) trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase , 1988 .
[8] M. Gotsman,et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. , 1985, The New England journal of medicine.
[9] P. Kudenchuk,et al. Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. , 1990, Journal of the American College of Cardiology.
[10] K. Lee,et al. A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction. , 1989, Circulation.
[11] R. Califf,et al. Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction. , 1988, Circulation.
[12] R. Collins,et al. SIGNIFICANT REDUCTION IN MORTALITY WITH STREPTOKINASE GIVEN 7-24 HOURS AFTER PAIN ONSET , 1988, The Lancet.
[13] T. Feldman,et al. Evaluation of patients for the need of thrombolytic therapy in the prehospital setting. , 1989, Annals of emergency medicine.
[14] K. Lee,et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.
[15] E. Braunwald. Enhancing thrombolytic efficacy by means of "front-loaded" administration of tissue plasminogen activator. , 1989, Journal of the American College of Cardiology.
[16] M. Eisenberg,et al. Delay between onset of chest pain and seeking medical care: the effect of public education. , 1989, Annals of emergency medicine.
[17] David O. Williams,et al. Improved infarct artery patency using a new modified regimen of t-PA: results of the pre-hospital administration of t-PA (PATS) pilot trial , 1990 .
[18] J. Anderson,et al. Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. , 1990, The American journal of cardiology.
[19] R. Califf,et al. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial. , 1987, Journal of the American College of Cardiology.
[20] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.. LONG-TERM EFFECTS OF INTRAVENOUS THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: FINAL REPORT OF THE GISSI STUDY , 1987, The Lancet.
[21] S. Sherry,et al. Appraisal of various thrombolytic agents in the treatment of acute myocardial infarction. , 1987, The American journal of medicine.
[22] M. Sherrid,et al. OUT-OF-HOSPITAL, PARAMEDIC ADMINISTERED STREPTOKINASE FOR ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.
[23] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.
[24] Harold T. Dodge,et al. Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* , 1987 .
[25] Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. , 1986 .
[26] E. Ruiz,et al. An analysis of time delays preceding thrombolysis for acute myocardial infarction. , 1989, JAMA.
[27] U. Tebbe,et al. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. , 1989, Journal of the American College of Cardiology.